Plasma osteopontin in acute liver failure

Area of Science:

• Immunology
• Hepatology
• Biochemistry

Background:

• Osteopontin (OPN) is a phosphoglycoprotein involved in immune cell activation.
• OPN is expressed in Kupffer cells and plays a role in liver inflammation.
• Measuring plasma OPN in acute liver failure (ALF) can elucidate its role in massive hepatocyte injury.

Purpose of the Study:

• To measure plasma osteopontin (OPN) levels in patients with acute liver failure (ALF).
• To investigate the correlation between OPN levels and the severity of liver injury in ALF.
• To compare OPN levels in ALF patients with those in healthy individuals and patients with other inflammatory conditions.

Main Methods:

• Plasma OPN levels were quantified using a Quantikine® ELISA assay.
• The study included 105 consecutive ALF patients.
• Control groups comprised 40 rheumatoid arthritis patients and 35 healthy subjects undergoing spine fusion surgery.

Main Results:

• ALF patients exhibited 10- to 30-fold higher median plasma OPN levels (1055 ng/mL) compared to healthy controls (41 ng/mL).
• OPN levels were highest in acetaminophen- and ischemia-related ALF, correlating with aminotransferase levels (R=0.47 for AST, p<0.001).
• Elevated OPN levels were also observed in rheumatoid arthritis and post-spine fusion surgery patients, but were lower than in ALF.

Conclusions:

• Plasma OPN levels correlate with the degree of liver necrosis in ALF.
• Extremely high OPN levels were associated with hyperacute liver injury and favorable outcomes.
• The potential protective role of OPN in mitigating ALF progression requires further investigation.